Suppr超能文献

[动脉粥样硬化与钙拮抗剂]

[Atheroma and calcium antagonists].

作者信息

Lechat P, Hadjiisky P

机构信息

Service de Pharmacologie, C.H.U. Pitié-Salpétrière, Paris.

出版信息

Therapie. 1993 Nov-Dec;48 Spec No:665-70.

PMID:8091352
Abstract

Calcic ions play a role in the initial and chronic development of atherosclerosis lesions. Demonstration of anti atherogenic properties of calcium antagonists has open a new therapeutic approach of atherosclerosis and of its complications. Mechanism of protection remains unclear but it is essentially a preventive effect requiring very early administration before onset of lesions. Several experimental studies have shown that calcium antagonists could reduce cholesterol content of arterial wall without any modification of lipid plasma or profile. Several other mechanisms have been proposed but none of them can actually explain the observed preventive effect of these drugs. The clinical relevance in human of such a preventive effect of calcium antagonists requires further investigations.

摘要

钙离子在动脉粥样硬化病变的初始和慢性发展过程中发挥作用。钙拮抗剂抗动脉粥样硬化特性的证实为动脉粥样硬化及其并发症开辟了一种新的治疗方法。保护机制尚不清楚,但本质上是一种预防作用,需要在病变发生前非常早期给药。多项实验研究表明,钙拮抗剂可降低动脉壁胆固醇含量,而不改变血脂或血脂谱。还提出了其他几种机制,但实际上没有一种能够解释这些药物所观察到的预防作用。钙拮抗剂这种预防作用在人体中的临床相关性需要进一步研究。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验